Skip to content

Revenue at other companies

HTF
Heartflow, Inc. Common StockHTFL
$52.59M+41.3%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$666.95M-53.0%
DJT
Trump Media & Technology GroupDJT
$871.2K+6.1%
ADMA Biologics logo
ADMA BiologicsADMA
$114.49M-0.3%
Minerals Technologies logo
Minerals TechnologiesMTX
$546.9M+11.2%
Lincoln Educational Services Corporation logo
Lincoln Educational Services CorporationLINC
$143.96M+22.5%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s revenue?
Harmony Biosciences Holdings, Inc. (HRMY) reported revenue of $215.39M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s revenue changed year-over-year?
Harmony Biosciences Holdings, Inc.'s revenue increased by 16.6% year-over-year, from $184.73M to $215.39M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s revenue?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s revenue has grown at a 29.9% compound annual growth rate (CAGR), from $305.44M to $868.45M.